Cyclin-dependent Kinase Inhibitor 2A (p16ink4a) Expression is Associated with Improved Survival in Patients with Pancreatic Adenocarcinoma Chang, D. T., Pai, R., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A., Ford, J. M., Koong, A. C. ELSEVIER SCIENCE INC. 2009: S57

View details for DOI 10.1016/j.ijrobp.2009.07.150

View details for Web of Science ID 000270573600121